CN107311863B - Preparation method and application of chloroformate derivative - Google Patents

Preparation method and application of chloroformate derivative Download PDF

Info

Publication number
CN107311863B
CN107311863B CN201710609223.1A CN201710609223A CN107311863B CN 107311863 B CN107311863 B CN 107311863B CN 201710609223 A CN201710609223 A CN 201710609223A CN 107311863 B CN107311863 B CN 107311863B
Authority
CN
China
Prior art keywords
formula
temperature
reaction
cep
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710609223.1A
Other languages
Chinese (zh)
Other versions
CN107311863A (en
Inventor
李世洪
程柯
王福雄
左翔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lier Chemical Co Ltd
Original Assignee
Lier Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lier Chemical Co Ltd filed Critical Lier Chemical Co Ltd
Priority to CN201710609223.1A priority Critical patent/CN107311863B/en
Publication of CN107311863A publication Critical patent/CN107311863A/en
Application granted granted Critical
Publication of CN107311863B publication Critical patent/CN107311863B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00Preparation of esters of carbonic or haloformic acids
    • C07C68/02Preparation of esters of carbonic or haloformic acids from phosgene or haloformates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00Preparation of esters of carbonic or haloformic acids
    • C07C68/08Purification; Separation; Stabilisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a preparation method and application of a chloroformate derivative, belongs to the field of chemical synthesis, and aims to provide a novel chloroformate derivative preparation method capable of meeting the industrial production requirements. In the method, the chloroformate derivative is represented by the following formula (II), and comprises the following steps: reacting a compound shown in a formula (I) with phosgene to prepare a compound shown in a formula (II); the reaction equation is as follows:

Description

Preparation method and application of chloroformate derivative
Technical Field
The invention relates to the field of chemical synthesis, in particular to a preparation method and application of a chloroformate derivative.
Background
The chloroformate derivative is used as an important pharmaceutical chemical intermediate and has important application value. At present, a new method for preparing chloroformate derivatives is urgently needed to meet the requirement of industrial application.
Disclosure of Invention
The invention aims to: aiming at the problems, the preparation method and the application of the chloroformate derivative are provided. The invention has the advantages of simple and safe production and the like, and the prepared product has higher product purity and reaction yield, and the three wastes are simple and convenient to treat, have higher application value and wide application prospect, and are worthy of large-scale popularization and application.
In order to achieve the purpose, the invention adopts the following technical scheme:
a method for preparing a chloroformate derivative represented by the following formula (II), comprising the steps of:
reacting a compound shown in a formula (I) with phosgene to prepare a compound shown in a formula (II); the reaction equation is as follows:
Figure BDA0001359108520000011
wherein R is C1-C4N is 1, 2 or 3.
Said C is1-C4Alkyl of (A) means C1、C2、C3、C4The alkyl group of (1) is a straight-chain or branched alkyl group having 1 to 4 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, sec-butyl, etc.
Reacting the compound of formula (I) with phosgene at 0-5 ℃.
Further, R is n-propyl.
Further, n is 1.
At a temperature lower than the boiling point of phosgene, firstly, dissolving phosgene in an organic solvent, and then reacting the organic solvent with the compound of the formula (I) at a temperature of 0-5 ℃ to prepare the compound of the formula (II).
The organic solvent is selected from one or more of alkane solvents, halogenated hydrocarbon solvents, aromatic hydrocarbon solvents and halogenated aromatic hydrocarbon solvents.
The organic solvent is toluene.
The mass ratio of the compound shown in the formula (I) to the organic solvent is 1: 0.5 to 5.
Further, the mass ratio of the compound of formula (I) to the organic solvent is 1: 2.
and (3) after the compound of the formula (I) and phosgene react at 0-5 ℃, introducing inert gas into the mixture for polishing treatment, and obtaining the compound of the formula (II) after the polishing treatment is finished.
The inert gas is nitrogen.
When the polishing treatment is carried out, the temperature of the solution is 0-50 ℃.
Further, when the polishing treatment was carried out, the temperature of the solution was 30 ℃.
Use of the foregoing process for the preparation of a compound of the formula:
Figure BDA0001359108520000021
wherein R is C1-C4N is 1, 2 or 3.
In view of the foregoing problems, the present invention provides a method for preparing chloroformate derivatives and use thereof. The preparation method comprises the following steps of A:
Figure BDA0001359108520000022
reacting a compound shown in a formula (I) with phosgene at 0-5 ℃ to prepare a compound shown in a formula (II);
wherein R represents C1-C4N represents 1, 2 or 3.
Further, the reaction is carried out by dissolving phosgene in an organic solvent and adding the compound of formula (I) at a temperature below the boiling point of phosgene.
And (2) after the compound of the formula (I) and phosgene react at 0-5 ℃, introducing inert gas into the compound of the formula (I) for light-dispelling treatment (namely introducing the inert gas into the solution, and dispelling residual phosgene from the solution until the content of free chlorine is less than 1%), and obtaining the compound of the formula (II) after the light-dispelling treatment is finished.
Further, the present invention also provides the use of the aforementioned preparation process for the preparation of a compound of formula (III), wherein R, n is as defined above and formula (III) is as follows:
Figure BDA0001359108520000023
the preparation method of the chloroformate derivative has the following advantages after being verified by a plurality of experiments:
(1) the reaction operation is simple and convenient, and the flow is short;
(2) the raw materials are dropwise added, so that the reaction control is safe;
(3) the method has high product purity and reaction yield and good economic benefit;
(4) the synthesis reaction only generates acid gas, the main components of the gas are hydrogen chloride and phosgene, the gas is absorbed by liquid alkali, the neutralized gas is used as high-salinity wastewater, and the three wastes are simply and conveniently treated.
In conclusion, the invention provides a set of preparation method suitable for industrial production of chloroformate derivatives, which has the advantages of simplicity, safety and high efficiency, higher product purity and reaction yield, simple and convenient three-waste treatment, higher application value and wide application prospect.
Detailed Description
All of the features disclosed in this specification, or all of the steps in any method or process so disclosed, may be combined in any combination, except combinations of features and/or steps that are mutually exclusive.
Any feature disclosed in this specification may be replaced by alternative features serving equivalent or similar purposes, unless expressly stated otherwise. That is, unless expressly stated otherwise, each feature is only an example of a generic series of equivalent or similar features.
In the present invention, the meanings of English abbreviations are as follows: DMAP: 4-dimethylaminopyridine; TEBAC: benzyltriethylammonium chloride.
EXAMPLE 12 preparation of Propoxyethyl chloroformate (CEP-1#)
In this example, the analytical instrument and method were as follows:
gas chromatography normalization method:
the instrument is as follows: agilent7820A, GC with FID detector (rear well);
② chromatographic column: HP-5, 30.0 m.times.0.32 mm.times.0.25 μm;
③ temperature of sample Inlet (INJ): 280 ℃; the split ratio is as follows: 10: 1;
chromatographic column conditions: constant current mode, N2Flow rate: 2.0 mL/min;
column temperature (COL): keeping the temperature at 60 ℃ for 2min, heating to 300 ℃ at the heating rate of 20 ℃/min, and keeping the temperature for 5 min;
detector (FID) conditions: the temperature is 300 ℃; h2Flow rate: 40mL/min, air flow rate: 400 mL/min; tail gas blowing flow: 25 mL/min;
seventh, solvent: dichloromethane;
the system adaptability experiment: the manual sample introduction repeatability experiment RSD is less than or equal to 5 percent;
ninthly, the main peak output time is as follows: CEP-0# (2.86min), CEP-1# (4.92 min).
The low boiling impurities are characterized by the following structures:
Figure BDA0001359108520000031
the boiling point of (A) is 35-36 ℃;
Figure BDA0001359108520000032
the boiling point of (B) was 83.5 ℃.
The reaction scheme is as follows:
Figure BDA0001359108520000033
the inventor conducts screening of a plurality of reaction processes and post-treatment conditions, including solvent and feeding modes, reaction temperature, solvent dosage and light-dispelling temperature.
1. Solvent and feeding mode screening
(1) Mode A
Directly taking the raw material CEP-0# as a solvent, adding the CEP-0# into a reaction bottle, and directly introducing phosgene for photochemical reaction at low temperature. The method comprises the following specific steps:
experiment number CEP-01: adding 1000g of raw material CEP-0# into a reaction bottle, directly introducing phosgene at-5-0 ℃ for photochemical reaction, controlling the photochemical reaction temperature at 0-5 ℃, and reacting until the CEP-0# is controlled to be less than 1% in GC (gas chromatography).
The content of CEP-1# is 84.7% and the total amount of low-boiling impurities is 11% by gas chromatography detection.
(2) Mode B
Directly taking the raw material CEP-0# as a solvent, adding part of the CEP-0# into a reaction bottle, introducing phosgene at the temperature of-5-0 ℃ for reaction for a period of time, and continuing and dropwise adding the rest CEP-0 #. The method comprises the following specific steps:
experiment number CEP-19: firstly, 200g of CEP-0#, stirring and cooling to-5-0 ℃, and introducing phosgene. After 2h, starting to dropwise add 800g of the residual CEP-0# raw material and continuously introducing phosgene until the dropwise addition is completed, controlling the reaction temperature to be 0-5 ℃ (namely photochemical temperature) in the dropwise addition process, and preserving the temperature to be 0-5 ℃ after the dropwise addition is completed to react until the CEP-0# is controlled to be less than 1% in a GC.
The content of CEP-1# detected by gas chromatography is 93.9%, and the total amount of low-boiling point impurities is 4%.
(3) Mode C
Adding toluene as solvent into a reaction bottle, introducing phosgene at low temperature for absorption, introducing phosgene and adding CEP-0# dropwise after a period of time. The method comprises the following specific steps:
experiment number CEP-16: adding 2000g of toluene, absorbing phosgene at the temperature of-5-0 ℃, then dropwise adding 1000g of CEP-0# at the temperature of 0-5 ℃ for photochemical reaction, controlling the reaction temperature at 0-5 ℃ in the dropwise adding process, and preserving the temperature at 0-5 ℃ after the dropwise adding is finished to react until the CEP-0# controlled in the GC is less than 1%.
The content of CEP-1# is 98.5% and the total amount of low-boiling point impurities is 0.7% by gas chromatography detection.
It can be seen that in both modes A, B, the selectivity of CEP-1# is less than 95% and the total low boiling impurities content is higher; and the photochemical reaction is carried out in the mode C, so that the intermediate reaction generated by low-boiling-point impurities can be greatly reduced, the generation of the low-boiling-point impurities can be greatly reduced, the selectivity of CEP-1# can reach more than 98%, and the total amount of the low-boiling-point impurities can be controlled to be about 1%.
Therefore, the method C has better effect, i.e. the reaction has better effect under the condition of the existence of the solvent.
2. Screening of reaction temperature
The screening of photochemical reaction temperature was carried out under different temperature conditions by using CEP-0# and toluene as solvents and adding phosgene and dripping CEP-0# respectively, and the experimental data are shown in the following Table 1.
TABLE 1
Experiment number Solvent and feeding mode Actinic temperature CEP-1# content Total amount of low boilers Reaction time
CEP-17 Mode C 0~5℃ 97.4% 1.1% 3.5h
CEP-04 Mode B -5~0℃ 90.5% 8.1% 8h
CEP-03 Mode C -5~0℃ 96% 2.5% 4.5h
CEP-19 Mode B 0~5℃ 93.9% 4% 3h
CEP-18 Mode C 5~10℃ 93.5% 4.5% 3h
The results show that the selectivity of CEP-1# is obviously influenced by photochemical temperature and time, and the reaction time is prolonged due to the fact that the photochemical temperature is too low, and the total amount of low-boiling products is obviously increased; too high a photochemical temperature, however, increases the reaction rate and likewise the total content of low-boiling products.
Therefore, the reaction temperature and time must be controlled, and the inventor confirms that the preferable photochemical temperature is 0-5 ℃ through the experimental verification of multiple batches.
3. Screening of solvent dosage
The amount of solvent used was selected and the results are shown in table 2 below.
TABLE 2
Figure BDA0001359108520000051
The results show that CEP-0 #: toluene ═ 1: the 2(w/w) effect is better.
By optimizing photochemical reaction conditions and comparing selectivity of CEP-1#, the currently preferred photochemical conditions are determined, namely, toluene is used as a solvent, phosgene absorption is carried out at low temperature, CEP-0# is dripped for photochemical reaction after 2 hours under the condition of keeping continuous phosgene introduction, the dripping speed is controlled, the photochemical reaction is carried out at 0-5 ℃, and after the photochemical reaction is finished, a reaction liquid is obtained.
4. Screening of reaction liquid post-treatment light-dispelling (gas purging) temperature
The reaction solutions were taken and subjected to light-driving under different temperature conditions in such a way that the temperature was slowly increased from the actinic temperature (avoiding too fast gas evolution) to the light-driving temperature, and the temperature was maintained until the light-driving was completed (free chlorine content < 1%), and the experimental results are shown in table 3 below.
TABLE 3
Figure BDA0001359108520000052
The results show that the light-driving temperature is too low, and the content of low-boiling products is increased more; too high a temperature for light-driving also increased the low boiling products more and the CEP-1# color became darker.
Therefore, the preferred temperature for light-expelling is 30 ℃.
5. Confirmation of optimized reaction conditions
With CEP-0 #: toluene ═ 1: taking 2(w/w) toluene as a solvent, absorbing phosgene at a low temperature (-5-0 ℃), then dropwise adding CEP-0# at a temperature of 0-5 ℃ for photochemical reaction, continuously introducing phosgene during the dropwise adding process until the photochemical reaction is finished, slowly heating to 30 ℃, using nitrogen gas for light removal at 30 ℃, and transferring the obtained product to a CEP-1# dropwise adding tank for later use after the light removal is finished.
EXAMPLE 22 preparation of propoxychloroethane (CEP)
In this example, the analytical instrument and method were as follows:
gas chromatography normalization method:
the instrument is as follows: agilent7820A, GC with FID detector (rear well);
② chromatographic column: HP-5, 30.0 m.times.0.32 mm.times.0.25 μm;
③ temperature of sample Inlet (INJ): 280 ℃; the split ratio is as follows: 10: 1;
chromatographic column conditions: constant current mode, N2Flow rate: 2.0 mL/min;
column temperature (COL): keeping the temperature at 60 ℃ for 2min, heating to 300 ℃ at the heating rate of 20 ℃/min, and keeping the temperature for 5 min;
detector (FID) conditions: the temperature is 300 ℃; h2Flow rate: 40mL/min, air flow rate: 400 mL/min; tail gas blowing flow: 25 mL/min;
seventh, solvent: dichloromethane;
the system adaptability experiment: the manual sample introduction repeatability experiment RSD is less than or equal to 5 percent;
ninthly, the main peak output time is as follows: CEP-1# (4.92min), CEP (3.01 min).
The reaction scheme is as follows:
Figure BDA0001359108520000061
the inventor carries out the screening of feeding mode, catalyst type and dosage.
1. Feeding mode and CEP-1 #/toluene solution concentration
Using TEBAC as a catalyst, and optimizing the decarboxylation reaction at the temperature of 110-130 ℃:
(1) mode D
Paving the bottom with partial CEP-1 #/toluene solution, adding a catalyst, heating to 110 ℃, refluxing toluene, dropwise adding the rest CEP-1 #/toluene solution after decarboxylation reaction is initiated, controlling the dropwise adding speed to keep the decarboxylation reaction temperature at 110-125 ℃, and preserving heat until the decarboxylation reaction is finished after the dropwise adding is finished. The method comprises the following specific steps:
adding 50g of CEP-1 #/toluene solution and 10g of TEBAC into a 500mL four-mouth bottle, heating to 110 ℃ under a stirring state, refluxing toluene, dropwise adding the rest 250g of CEP-1 #/toluene solution after decarboxylation reaction is initiated, controlling the dropwise adding speed to maintain the decarboxylation reaction temperature at 110-125 ℃, and preserving heat and stirring until the decarboxylation reaction is completed after the dropwise adding.
(2) Mode E
And (3) paving a pure toluene solvent, adding a catalyst, heating to 110 ℃, refluxing toluene, beginning to dropwise add a CEP-1 #/toluene solution, controlling the dropwise adding speed to maintain the decarboxylation reaction temperature at 110-125 ℃, and preserving heat until the decarboxylation reaction is finished after the dropwise adding is finished. The method comprises the following specific steps:
adding 50g of toluene solution and 10g of TEABAC into a 500mL four-mouth bottle, heating to 110 ℃ under a stirring state, refluxing toluene, starting to dropwise add 300g of CEP-1 #/toluene solution, controlling the dropwise adding speed to maintain the decarboxylation reaction temperature at 110-125 ℃, preserving heat and stirring until the decarboxylation reaction is finished after the dropwise adding.
The results of the experiment are shown in table 4 below.
TABLE 4
Figure BDA0001359108520000071
The results show that the decarboxylation reaction carried out in the formula D has a higher yield, a higher product purity and a minimum impurity content.
2. The kind and amount of catalyst
Under the condition of the same toluene dosage, the same feeding mode and decarboxylation temperature are adopted, catalysts of different types and proportions are adopted to carry out decarboxylation reaction, and the experimental results are shown in the following table 5.
TABLE 5
Figure BDA0001359108520000072
Figure BDA0001359108520000081
The results show that DMAP is preferred as the catalyst because DMAP is less used, the yield is high and the product purity is high.
The invention is not limited to the foregoing embodiments. The invention extends to any novel feature or any novel combination of features disclosed in this specification and any novel method or process steps or any novel combination of features disclosed.

Claims (7)

1. A method for preparing a chloroformate derivative, characterized in that the chloroformate derivative is represented by the following formula (II),
the reaction equation is as follows:
Figure FDA0002840710720000011
wherein R is n-propyl, and n is 1;
the method comprises the following specific steps:
at a temperature lower than the boiling point of phosgene, firstly, dissolving phosgene in an organic solvent, and then reacting the organic solvent with a compound of a formula (I) at a temperature of 0-5 ℃ to prepare a compound of a formula (II); the organic solvent is toluene.
2. The method of preparing a chloroformate derivative according to claim 1, wherein the mass ratio of the compound of formula (I) to the organic solvent is 1: 2.
3. the method for preparing a chloroformate derivative according to any one of claims 1 to 2, wherein after the reaction between the compound of formula (I) and phosgene is completed at 0 to 5 ℃, an inert gas is introduced into the compound of formula (I) to perform a quenching treatment, and after the quenching treatment is completed, the compound of formula (II) is obtained.
4. The method of producing a chloroformate derivative according to claim 3, wherein the temperature of the solution at the time of the light-expelling treatment is 30 ℃.
5. The method of preparing a chloroformate derivative according to claim 3, wherein said inert gas is nitrogen.
6. Use of a process according to any one of claims 1-2, 4, 5 for the preparation of a compound of the formula:
Figure FDA0002840710720000012
wherein R is n-propyl and n is 1.
7. Use of the process of claim 3 for the preparation of a compound of the formula:
Figure FDA0002840710720000021
wherein R is n-propyl and n is 1.
CN201710609223.1A 2017-07-25 2017-07-25 Preparation method and application of chloroformate derivative Active CN107311863B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710609223.1A CN107311863B (en) 2017-07-25 2017-07-25 Preparation method and application of chloroformate derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710609223.1A CN107311863B (en) 2017-07-25 2017-07-25 Preparation method and application of chloroformate derivative

Publications (2)

Publication Number Publication Date
CN107311863A CN107311863A (en) 2017-11-03
CN107311863B true CN107311863B (en) 2021-03-23

Family

ID=60178495

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710609223.1A Active CN107311863B (en) 2017-07-25 2017-07-25 Preparation method and application of chloroformate derivative

Country Status (1)

Country Link
CN (1) CN107311863B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115508479B (en) * 2022-06-24 2023-07-07 常州制药厂有限公司 Derivatization analysis method of n-hexyl chloroformate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101389597A (en) * 2005-12-29 2009-03-18 谢尔英·普劳有限公司 Carbonates of fenicol antibiotics

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101389597A (en) * 2005-12-29 2009-03-18 谢尔英·普劳有限公司 Carbonates of fenicol antibiotics

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Optical methyl 2-chloropropionate synthesis by decomposition of methyl 2-(chlorocarbonyloxy)propionate with hexaalkylguanidinium chloride hydrochloride;Frederic Violleau等;《Tetrahedron》;20021231;第58卷;第8607-8612页 *
Synthesis and in vitro evaluation of S-acyl-3-thiopropyl prodrug of Foscarnet;Valerie Gagnard等;《Bioorganic & Medicinal Chemistry》;20041231;第12卷;第1393-1402页 *
光气法合成二乙二醇双氯甲酸酯;张争争等;《工程与材料科学》;20141231(第6期);第77页 *

Also Published As

Publication number Publication date
CN107311863A (en) 2017-11-03

Similar Documents

Publication Publication Date Title
EP2327680B1 (en) Process for producing 1-chloro-3,3,3-trifluoropropene
CN108689876B (en) Preparation method of sodium 8- (2-hydroxybenzamido) caprylate
CN107311863B (en) Preparation method and application of chloroformate derivative
CN104387236B (en) A kind of propilolic alcohol, 1,4-butynediols and methenamine three coproduction continuous producing method
US20170291866A1 (en) Production of Mixed Aldol Products from the Products of Hydroformylation Reactions
US20150376111A1 (en) Method for producing nitroalkanes in a microstructured reactor
EP3400206B1 (en) Improved processes for preparing halogenated alkanes
CN107216239B (en) Preparation method of chlorinated aliphatic ether
CN110818558A (en) Method and device for continuously preparing chloro pivaloyl chloride by using micro-channel
CN108026015B (en) Process for producing (meth) acrylic acid
JP5602143B2 (en) A method for reducing the formation of by-product dinitrobenzene in the production of mononitrobenzene
EP3849340B1 (en) Process for the manufacture of omega nitrooxy-1-alkanols
KR100862177B1 (en) Process for the epoxidation of olefins
CN106745066A (en) Produce, purify the safe technology and system of hydrogen cyanide
KR102071455B1 (en) Method for preparing curcumin hydrogenation products
CN113511954B (en) Continuous flow preparation method of 1,2, 3-trichloropropane
CN111116593A (en) Continuous and low-cost preparation method of imatinib
CN113024390B (en) Synthesis method of 3&#39;,5&#39; -dichloro-2, 2-trifluoro acetophenone derivative
CN109928862B (en) Novel preparation method of alpha-vinylchloride cyclopropane
CN112745207B (en) Method for producing methyl isobutyl ketone by acetone one-step method
CN111004083B (en) Method for purifying alkene organic compound
CN104262439B (en) A kind of method with 4-AD one-step synthesis method testosterone
US20110046413A1 (en) Process for preparing 4-pentenoic acid
CN104058928A (en) Method for increasing production capacity of device in bromine-containing hydrofluoroalkane synthesis
JP5788809B2 (en) Method and assembly apparatus for liquid phase reaction

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant